Evaluation of Anti-mullerian Hormone Levels as Predictive of IVF Outcomes in Women Over 38 Years Old

R

Reproductive Medicine Associates of New Jersey

Status

Completed

Conditions

IVF Patients Over 38 Years Old
Inhibin B Levels
AMH Levels

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01219387
RMA-00-09

Details and patient eligibility

About

The present study is designed to evaluate the basal serum levels of anti-mullerian hormone (AMH) and inhibin B as early predictors of ovarian response, implantation rate, and pregnancy rate in women 38 years old or older that are undergoing an IVF cycle.

Full description

Specifics aims are: a) to describe AMH and inhibin levels on day 3 previous to ART cycle; b) to analyze the association between these hormone levels and the retrieved metaphase II oocytes quantity; c) to analyze the association between these hormone levels and quality embryo score d) to analyze the association between these hormone levels and the number of gestational sacs per transferred-embryo (implantation rate); e) to analyze the association between these hormone levels and the pregnancy rate; f) to make a prediction model for pregnancy rate by using a multivariable regression analysis. Patient participation includes signing the consent and having additional tubes of blood drawn at a regularly scheduled blood draw. This blood is used to run the study tests (AMH and inhibin levels).

Enrollment

300 patients

Sex

Female

Ages

38 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

1. Women 38 years old or older at the time of initiating treatment

Exclusion criteria

  • Uterine disease: malformation, septum, submucosal myomas, endometrial polyps Advanced endometriosis with endometrioma (s)
  • No uterus
  • Single ovary

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems